Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis

Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis

Background: In steroid-refractory acute severe ulcerative colitis (ASUC), cyclosporine (CYS) or infliximab (IFX) may be considered as a second-line alternative to avoid colectomy. There are short-term data reported, but until now, there is no meta-analysis regarding long-term outcomes of CYS and IFX...

Full description

Bibliographic Details
Main Authors: Kata Szemes, Alexandra Soós, Péter Hegyi, Nelli Farkas, Adrienn Erős, Bálint Erőss, Emese Mezősi, Zsolt Szakács, Katalin Márta, Patrícia Sarlós
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Medicine
Subjects:
steroid-refractory
ulcerative colitis
cyclosporine
infliximab
colectomy
meta-analysis
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00338/full

Similar Items

Similar Items